131 related articles for article (PubMed ID: 37751436)
1. Suppression of migration and invasion by taraxerol in the triple-negative breast cancer cell line MDA-MB-231 via the ERK/Slug axis.
Xia YT; Zhang YQ; Chen L; Min L; Huang D; Zhang Y; Li C; Li ZH
PLoS One; 2023; 18(9):e0291693. PubMed ID: 37751436
[TBL] [Abstract][Full Text] [Related]
2. Research on the mechanisms of taraxerol for the treatment of gastric cancer effect based on network pharmacology.
Huo B; Song Y; Tan B; Li J; Zhang J; Zhang F; Chang L
Int J Immunopathol Pharmacol; 2022; 36():20587384211063962. PubMed ID: 34986036
[TBL] [Abstract][Full Text] [Related]
3. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
[TBL] [Abstract][Full Text] [Related]
4. XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer.
Xu S; Sun X; Luo L; Yang Y; Guo Q; Tang S; Jiang Z; Li Y; Han J; Gan W; Yang F; Zhang X; Liu Y; Sun C; He J; Liu M; Zuo D; Zhu W; Wu Y
Biomed Pharmacother; 2022 Nov; 155():113537. PubMed ID: 36113258
[TBL] [Abstract][Full Text] [Related]
5. Hydroxytyrosol and Oleuropein Inhibit Migration and Invasion of MDA-MB-231 Triple-Negative Breast Cancer Cell via Induction of Autophagy.
Lu HY; Zhu JS; Zhang Z; Shen WJ; Jiang S; Long YF; Wu B; Ding T; Huan F; Wang SL
Anticancer Agents Med Chem; 2019; 19(16):1983-1990. PubMed ID: 31333142
[TBL] [Abstract][Full Text] [Related]
6. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
7. All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action.
Mezquita B; Mezquita P; Pau M; Gasa L; Navarro L; Samitier M; Pons M; Mezquita C
Sci Rep; 2018 May; 8(1):7047. PubMed ID: 29728589
[TBL] [Abstract][Full Text] [Related]
8. [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC].
Xin H; Jiang D; Lü Z; Sun S; Kong J; Li F
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2474-7. PubMed ID: 26711213
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
10. Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB).
Yan F; Wu Z; Li Z; Liu L
Med Sci Monit; 2020 Sep; 26():e922814. PubMed ID: 32920591
[TBL] [Abstract][Full Text] [Related]
11. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
12. Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis.
Gao G; Liang X; Ma W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3839-3846. PubMed ID: 31556312
[TBL] [Abstract][Full Text] [Related]
13. NFIC1 inhibits the migration and invasion of MDA-MB-231 cells through S100A2-mediated inactivation of MEK/ERK pathway.
Zhang J; Wang Z; Liang Z; Jin C; Shi Y; Fan M; Hu X; Wan Y
Arch Biochem Biophys; 2023 Jan; 734():109497. PubMed ID: 36574914
[TBL] [Abstract][Full Text] [Related]
14. Hesperetin Inhibits TGF-β1-Induced Migration and Invasion of Triple Negative Breast Cancer MDA-MB-231 Cells via Suppressing Fyn/Paxillin/RhoA Pathway.
Lu Q; Lai Y; Zhang H; Ren K; Liu W; An Y; Yao J; Fan H
Integr Cancer Ther; 2022; 21():15347354221086900. PubMed ID: 35297710
[TBL] [Abstract][Full Text] [Related]
15. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
16. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway.
Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ
J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381
[TBL] [Abstract][Full Text] [Related]
17. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
[TBL] [Abstract][Full Text] [Related]
19. Chinese medicine formula 'Baipuhuang Keli' inhibits triple-negative breast cancer by hindering DNA damage repair via MAPK/ERK pathway.
Mi S; Liu X; Zhang L; Wang Y; Sun L; Yuan S; Cui M; Liu Y
J Ethnopharmacol; 2023 Mar; 304():116077. PubMed ID: 36572327
[TBL] [Abstract][Full Text] [Related]
20. Cimicifuga dahurica extract inhibits the proliferation, migration and invasion of breast cancer cells MDA-MB-231 and MCF-7 in vitro and in vivo.
Jia H; Wang X; Liu W; Qin X; Hu B; Ma Q; Lv C; Lu J
J Ethnopharmacol; 2021 Sep; 277():114057. PubMed ID: 33771643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]